Clinical Trial Update: The PREDICT Registry:

View source ↗

Summary

A PREDICT Registry study sponsored by PreludeDx is recruiting to collect data on ductal carcinoma in situ (Stage 0 breast cancer).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: PreludeDx | Conditions: DCIS, Stage 0 Breast Cancer | Status: RECRUITING